Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-Induced Dyskinesia - Related Studies

Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-Induced Dyskinesia

This study is not yet open for participant recruitment.

Study NCT00607451. Last updated on February 4, 2008. Information provided by Neurim Pharmaceuticals Ltd.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Levodopa-Induced Dyskinesia

2	Additional conditions recognized in this trial
		Dyskinesias
		Parkinson Disease

3	More general conditions related to this trial
		Basal Ganglia Diseases
		Brain Diseases
		Central Nervous System Diseases
		Movement Disorders
		Nervous System Diseases
		Neurodegenerative Diseases
		Neurologic Manifestations
		Parkinsonian Disorders
		Signs and Symptoms

4	Interventions listed in this trial
		Neu-120

5	Sponsors listed in this trial
		Neurim Pharmaceuticals Ltd.